Literature DB >> 17634465

Atherothrombosis--wave goodbye to combined anticoagulation and antiplatelet therapy?

Emile R Mohler.   

Abstract

Mesh:

Substances:

Year:  2007        PMID: 17634465     DOI: 10.1056/NEJMe078106

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  Clopidogrel versus aspirin in patients with recent ischemic stroke and established peripheral artery disease: an economic evaluation in a Chinese setting.

Authors:  Te Li; Maobai Liu; He Ben; Zhenxing Xu; Han Zhong; Bin Wu
Journal:  Clin Drug Investig       Date:  2015-06       Impact factor: 2.859

2.  Cardiovascular drugs: implications for dental practice. Part 2--antihyperlipidemics and antithrombotics.

Authors:  Daniel E Becker
Journal:  Anesth Prog       Date:  2008

Review 3.  Controversies and future perspectives of antiplatelet therapy in secondary stroke prevention.

Authors:  Ralph Weber; Hans-Christoph Diener
Journal:  J Cell Mol Med       Date:  2010-10       Impact factor: 5.310

4.  Anithrombotic prevention in vascular disease: bases for a new strategy in antithrombotic therapy.

Authors:  Raul Altman
Journal:  Thromb J       Date:  2007-08-29

5.  Thrombin inhibition by dabigatran attenuates atherosclerosis in ApoE deficient mice.

Authors:  Simon Pingel; Vedat Tiyerili; Jens Mueller; Nikos Werner; Georg Nickenig; Cornelius Mueller
Journal:  Arch Med Sci       Date:  2014-02-23       Impact factor: 3.318

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.